基本情報
- 標準SMILES
CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C- InChIKey
LEBVLXFERQHONN-UHFFFAOYSA-N- 分子式
- C18H28N2O
- 平均分子量
- 288.4 g/mol
- 単同位体質量
- 288.22016352
概要
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide is a piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline. It is a piperidinecarboxamide, a tertiary amino compound and an aromatic amide. It is a conjugate base of a 1-butyl-2-[(2,6-dimethylphenyl)carbamoyl]piperidinium.
名称と識別子
- 優先名称
- Bupivacaine (USAN:INN:BAN)
- IUPAC
- 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
- 現地名
- ブピバカイン
- 英語名
- Bupivacaine
- 分子式
- C18H28N2O
- 分子量
- 288.43
名称と別名
名称をさらに表示
データベース識別子
- CAS
2180-92-9、38396-39-3- PubChem CID
- 2474
- DTXSID
DTXSID2022703- ChEBI
CHEBI:77431- UNII
- Y8335394RO
- Nikkaji
- J7.351B
物性
構造計算による物性
- XLogP
- 3.4
- 極性表面積
- 32.3 Ų
- 水素結合供与体数
- 1
- 水素結合受容体数
- 2
- 回転可能結合数
- 5
- 重原子数
- 21
- 形式電荷
- 0
- 複雑度
- 321
実験および物理化学的性質
Collision Cross Section
173.1 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]
180.07 Ų [M+H-H2O]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
物理化学的性質
- 融点
- 107.5 · 107.5-108°
- 沸点
- 430.65 °C · 430.65°C (rough estimate)
- 比重(密度)
- 1.0238 · 1.0238 (rough estimate)
- 屈折率
- 1.57 · 1.5700 (estimate)
- 酸解離定数(Pka)
- 8.09 · 8.09; also reported as 8.17(at 25℃)
- 水溶解度
- 101.5 mg/L · 101.5mg/L(25℃)
- InChI
- InChI=1S/C18H28N2O/c1-4-5-12-20-13-7-6-11-16(20)18(21)19-17-14(2)9-8-10-15(17)3/h8-10,16H,4-7,11-13H2,1-3H3,(H,19,21)
- InChIKey
- LEBVLXFERQHONN-UHFFFAOYSA-N
- SMILES
- C1(CCCCN1CCCC)C(=O)NC1C(C)=CC=CC=1C
- CAS データベース
- 2180 · 2180-92-9(CAS DataBase Reference)
- NISTの化学物質情報
- 2 · 2-Piperidinecarboxamide, 1-butyl-n-(2,6-dimethylphenyl)-(2180-92-9)
- EPAの化学物質情報
- 2 · 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)- (2180-92-9)
安全と法規制
安全データ
- ridadr
- 2811
- risk_code
- 26/27/28-38-41
- hazard_code
- T+
- safety_code
- 22-26-36/37/39-45
化学と産業
薬理情報
用途と製造
応用分野
使用Like lidocaine and mepivacaine, bupivacaine is used in infiltration, spinal, and epidural anesthesia in blocking nerve transmission. Its most distinctive property is its long-lasting action. It is used for surgical intervention in urology and in lower thoracic surgery from 3 to 5 h in length, and in abdominal surgery lasting from 45 to 60 min. It is used to block the trifacial nerve, the sacral and brachial plexuses, in resetting dislocations, in epidural anesthesia, and during Cesarian sections.
一般的な説明Bupivacaine was synthesized simultaneously with mepivacainein 1957 but was at first overlooked because of the increasedtoxicity compared with mepivacaine. When themethyl on the cyclic amine of mepivacaine is exchanged fora butyl group the lipophilicity, potency and the duration ofaction all increase. Literature reports of cardiovascular toxicity,including severe hypotension and bradycardia, areabundant in the literature.91 Bupivacaine is highly bound toplasma proteins (95%), and thus the free concentration mayremain low until all of the protein binding sites are occupied.After that point, the plasma levels of bupivacaine rise rapidlyand patients may progress to overt cardiac toxicity withoutever showing signs of CNS toxicity. The cardiotoxicity ofbupivacaine is a result of its affinity to cardiac tissues and itsability to depress electrical conduction and predispose theheart to reentry types of arrhythmias. The cardiotoxicity ofbupivacaine was found to be significantly more prominentwith the “R” isomer, or the racemic mixture, thus the “S”stereoisomer is now on the market as levobupivacaine.
上流・下流製品情報
上流原料
サプライヤー50 社
関連反応
関連ノート
読み込み中…